AleAnna (ANNA) Stock Price, News & Analysis

Company Overview

AleAnna, Inc. engages in oil and gas exploration and production activities. It focuses on Italy's natural gas reserves and developing renewable energy solutions. The company was founded in 2007 and is headquartered in Dallas, TX.

Key Stats

• Today's Range: $3.50 to $3.68
• 50-Day Range: $2.63 to $3.82
• 52-Week Range: $2.31 to $10.64
• Volume: 169,263 shs
• Average Volume: 2.18 million shs
• Market Capitalization: $241.27 million
• P/E Ratio: 25.86
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

AleAnna Stock Analysis - MarketRank™

AleAnna scored higher than 27% of companies evaluated by MarketBeat, and ranked 1469th out of 1,682 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

AleAnna has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

AleAnna has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of AleAnna is 25.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.14.

Price to Earnings Ratio vs. Sector

The P/E ratio of AleAnna is 25.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.00.

Price to Book Value per Share Ratio

AleAnna has a P/B Ratio of 4.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.62% of the float of AleAnna has been sold short.

Short Interest Ratio / Days to Cover

AleAnna has a short interest ratio ("days to cover") of 1.51, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in AleAnna has recently decreased by 10.20%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

AleAnna does not currently pay a dividend.

Dividend Growth

AleAnna does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: N/A

News Sentiment

AleAnna has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for AleAnna this week, compared to 2 articles on an average week.

Search Interest

2 people have searched for ANNA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, AleAnna insiders have not sold or bought any company stock.

Percentage Held by Insiders

39.54% of the stock of AleAnna is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

38.10% of the stock of AleAnna is held by institutions.

Company Calendar

• Last Earnings: 5/14/2026
• Today: 7/21/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Trading
• Current Symbol: NASDAQ:ANNA
• Previous Symbol: NASDAQ:ANNA
• CIK: 1845123
• Web: www.swiftmerg.com
• Phone: 424-431-0030
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.14
• Trailing P/E Ratio: 25.86
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $1.80 million
• Net Margins: 17.43%
• Pretax Margin: 33.70%
• Return on Equity: 10.22%
• Return on Assets: 5.99%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.85
• Quick Ratio: 1.85

Sales & Book Value

• Annual Sales: $25.04 million
• Price / Sales: 9.64
• Cash Flow: $0.07 per share
• Price / Cash Flow: 48.46
• Book Value: $0.88 per share
• Price / Book: 4.11

Miscellaneous

• Outstanding Shares: 66,650,000
• Free Float: 40,299,000
• Market Cap: $241.27 million
• Optionable: N/A
• Beta: -1.63